| Index | — | P/E | 23.59 | EPS (ttm) | 1.66 | Insider Own | 22.56% | Shs Outstand | 97.66M | Perf Week | 3.87% |
| Market Cap | 3.82B | Forward P/E | 12.19 | EPS next Y | 3.21 | Insider Trans | -0.57% | Shs Float | 96.71M | Perf Month | 8.57% |
| Enterprise Value | 4.54B | PEG | 0.43 | EPS next Q | 0.25 | Short Float | 9.13% | Perf Quarter | -10.47% | ||
| Income | 185.00M | P/S | 1.14 | EPS this Y | -47.67% | Short Ratio | 5.24 | Perf Half Y | -10.51% | ||
| Sales | 3.36B | P/B | 3.64 | EPS next Y | 161.31% | ROA | 4.06% | Short Interest | 8.83M | Perf YTD | -19.36% |
| Book/sh | 10.75 | P/C | 2.64 | EPS next 5Y | 55.25% | ROE | 20.43% | 52W High | 58.75 -33.97% | Perf Year | -19.70% |
| Cash/sh | 14.81 | P/FCF | 5.49 | EPS past 3/5Y | -14.81% -9.32% | ROIC | 6.45% | 52W Low | 34.13 13.67% | Perf 3Y | 37.55% |
| Dividend Est. | 2.00 (5.16%) | EV/EBITDA | 12.68 | Sales past 3/5Y | 4.08% 3.82% | Gross Margin | 61.87% | Volatility | 3.66% 4.15% | Perf 5Y | -26.07% |
| Dividend TTM | 2.50 (6.44%) | EV/Sales | 1.35 | EPS Y/Y TTM | -34.71% | Oper. Margin | 9.52% | ATR (14) | 1.64 | Perf 10Y | 8.69% |
| Dividend Ex-Date | Nov 02, 2026 | Quick Ratio | 2.66 | Sales Y/Y TTM | 10.02% | Profit Margin | 5.50% | RSI (14) | 58.29 | Recom | 2.66 |
| Dividend Gr. 3/5Y | 1.02% 1.25% | Current Ratio | 2.66 | EPS Q/Q | -35.71% | SMA20 | 5.73% | Beta | 1.43 | Target Price | 41.20 |
| Payout | 104.09% | Debt/Eq | 2.06 | Sales Q/Q | 8.65% | SMA50 | 1.40% | Rel Volume | 0.74 | Prev Close | 39.16 |
| Employees | 3,309 | LT Debt/Eq | 2.06 | Earnings | Feb 04 | SMA200 | -11.33% | Avg Volume | 1.68M | Price | 38.80 |
| IPO Date | May 05, 2005 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -14.16% -4.65% | Net Debt/EBITDA | 2.00 | Volume | 1,234,664 | Change | -0.93% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-22-26 | Reiterated | Goldman Sachs | Sell | $32 → $35 |
| Oct-13-26 | Reiterated | Goldman Sachs | Sell | $36 → $32 |
| Oct-08-26 | Reiterated | Morgan Stanley | Underweight | $44 → $41 |
| Oct-07-26 | Reiterated | UBS | Neutral | $44 → $40 |
| Oct-06-26 | Reiterated | Capital One Financial | $45 → $38 | |
| Oct-01-26 | Reiterated | Goldman Sachs | Sell | $40 → $36 |
| Jul-24-26 | Reiterated | Morgan Stanley | Underweight | $47 → $44 |
| Jul-09-26 | Reiterated | Morgan Stanley | Underweight | $52 → $47 |
| Jun-12-26 | Reiterated | Goldman Sachs | Sell | $45 → $40 |
| Jun-09-26 | Reiterated | UBS | Neutral | $45 → $44 |
Lazard, Inc. operates as a financial advisory and asset management firm in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through two segments, Financial Advisory and Asset Management. The Financial Advisory segment offers financial advisory services, such as mergers and acquisitions, capital markets, shareholder, sovereign, geopolitical, and other strategic advisory services, as well as restructuring and liability management, and capital raising and placement services. This segment offers its services to corporate, partnership, institutional, government, sovereign, and individual clients to various industry areas, including consumers and retail; financial institutions; financial sponsors; healthcare and life sciences; industrials; media, entertainment, and sports; power, energy, and infrastructure; real estate; technology; and telecom and digital infrastructure. The Asset Management segment offers a range of investment solutions; investment and wealth management services in equity and fixed income strategies; asset allocation strategies; and alternative investments and private equity funds to corporations, public funds, sovereign entities, endowments and foundations, labor funds, financial intermediaries, and private clients. Lazard, Inc. was incorporated in 1848 and is headquartered in New York, New York.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,360 | 3,186 | 3,086 | 2,551 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,282 | 2,173 | 2,003 | 1,946 | — | — | — | — | — | |
| Gross Profit | 2,080 | 1,013 | 1,083 | 605 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 886 | 118 | 427 | 431 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 873 | 480 | 270 | 254 | — | — | — | — | — | |
| Operating Income | 321 | 415 | 386 | -80 | — | — | — | — | — | |
| Interest Expense | 91 | 88 | 88 | 78 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 38 | 0 | 88 | 78 | — | — | — | — | — | |
| Net Income Before Taxes | 268 | 328 | 386 | -80 | — | — | — | — | — | |
| Income Taxes | 69 | 77 | 100 | -23 | — | — | — | — | — | |
| Consolidated Net Income | 185 | 237 | 280 | -75 | — | — | — | — | — | |
| Net Income From Continuing Operations | 199 | 251 | 287 | -57 | — | — | — | — | — | |
| Net Income | 185 | 237 | 280 | -75 | — | — | — | — | — | |
| EPS (Recurring) | 1.83 | 2.43 | 2.93 | -0.90 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.83 | 2.43 | 2.93 | -0.90 | — | — | — | — | — | |
| EPS (Diluted) | 1.66 | 2.17 | 2.68 | -0.90 | — | — | — | — | — | |
| EBITDA | 358 | 449 | 511 | 41 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 23.37 | 22.38 | 19.21 | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.17 | 1.48 | 1.55 | 1.21 | — | — | — | — | — | |
| Gross Margin | 61.90 | 31.80 | 35.09 | 23.72 | — | — | — | — | — | |
| Operating Margin | 9.55 | 13.03 | 12.51 | -3.14 | — | — | — | — | — | |
| Net Margin | 5.51 | 7.44 | 9.07 | -2.94 | — | — | — | — | — | |
| Shares Outstanding | 101 | 97 | 93 | 89 | — | — | — | — | — | |
| Market Capitalization | 3,918 | 4,710 | 4,788 | 3,097 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Orszag Peter Richard | CEO & Chairman | Aug 25 '26 | Sale | 43.52 | 125,000 | 5,440,038 | 260,942 | Aug 26 |
| Orszag Peter Richard | CEO & Chairman | Aug 24 '26 | Option Exercise | 0.00 | 250,000 | 0 | 460,942 | Aug 26 |
| Hogbin Christopher | CEO Asset Management | Mar 19 '26 | Sale | 39.37 | 3,944 | 155,275 | 11,829 | Mar 19 |
| Hogbin Christopher | CEO Asset Management | Mar 18 '26 | Sale | 40.37 | 7,885 | 318,317 | 15,773 | Mar 19 |
| Hogbin Christopher | CEO Asset Management | Mar 17 '26 | Option Exercise | 0.00 | 48,332 | 0 | 48,332 | Mar 19 |
| Orszag Peter Richard | CEO & Chairman | Mar 17 '26 | Sale | 40.76 | 69,170 | 2,819,274 | 210,942 | Mar 18 |
| Orszag Peter Richard | CEO & Chairman | Mar 16 '26 | Option Exercise | 0.00 | 138,340 | 0 | 321,614 | Mar 18 |
| Gathy Michael | Chief Accounting Officer | Mar 02 '26 | Option Exercise | 0.00 | 2,251 | 0 | 2,251 | Mar 04 |
| Soto Alexandra | Chief Operating Officer | Mar 02 '26 | Option Exercise | 0.00 | 64,743 | 0 | 178,615 | Mar 04 |
| Farr Tracy | Chief Financial Officer | Mar 02 '26 | Option Exercise | 0.00 | 5,903 | 0 | 5,903 | Mar 04 |
| Orszag Peter Richard | CEO & Chairman | Sep 16 '25 | Sale | 54.09 | 32,475 | 1,756,573 | 183,274 | Sep 17 |
| Orszag Peter Richard | CEO & Chairman | Sep 15 '25 | Option Exercise | 0.00 | 64,949 | 0 | 235,234 | Sep 17 |
| Russo Evan L | CEO of Asset Management | Sep 11 '25 | Sale | 56.95 | 50,000 | 2,847,600 | 227,915 | Sep 11 |
| Russo Evan L | CEO of Asset Management | Sep 10 '25 | Sale | 55.71 | 25,000 | 1,392,660 | 277,915 | Sep 11 |
| Gathy Michael | Chief Accounting Officer | Sep 10 '25 | Sale | 55.37 | 617 | 34,163 | 0 | Sep 11 |